In a new job - March 25, 2020
Nordic Nanovector appoints new CMO
Nordic Nanovector appoints Dominic Smethurst as Interim Chief Medical Officer with immediate effect. Smethurst replaces Lisa Rojkjaer, who after a handover period will leave Nordic Nanovector to pursue other career opportunities. “I am pleased that we have been able to appoint Dominic as our new Interim CMO. He is a very experienced and commercially focused […]
In a new job - March 20, 2020
Nordic Nanovector proposes board change
Nordic Nanovector has announced that its Nomination Committee has nominated Dr Karin Meyer for election as a Non-executive Director at the company’s Annual General Meeting. The company also notes that Gisela Schwab, who has served as a Non-executive Director on the Board of Nordic Nanovector since March 2015 has, due to increased workload, responsibilities and […]
In a new job - March 12, 2020
Umeå Biotech Incubator strengthens its team
Umeå Biotech Incubator (UBI) has appointed a new Business Coach and Community Manager. “The pressure is on! Right now we have a lot of ideas developing at our incubator and several of our companies are looking to take the next step. That’s why it is so important we have sufficient resources to handle this growth,” […]
In a new job - March 4, 2020
Scandinavian Biopharma appoints a new researcher
Scandinavian Biopharma announces that Morgan Hjorth has joined their team. Morgan Hjorth recently graduate from Karolinska Institute and Royal Institute of Technology (KTH) with two bachelor’s degrees and one Master degree of Science in Medical Biotechnology Engineering. “It feels great to be a part of Scandinavian Biopharma. It’s really motivating to work with the late […]
In a new job - March 2, 2020
Oncopeptides appoints Karolina Vilval as General Counsel
Oncopeptides has announced that Karolina Vilval has been appointed as General Counsel of Oncopeptides. Karolina has 15 years of experience from different positions at Swedish Orphan Biovitrum. Prior to joining Oncopeptides, she served as Associate Legal Director at Gilead Sciences Sweden AB for business area Oncology, HIV and Inflammation. She will be a member Oncopeptides’ […]
In a new job - February 28, 2020
Nordic Nanovector appoints new interim Chief Executive Officer
Nordic Nanovector has announced that Lars Nieba has been appointed interim Chief Executive Officer with immediate effect. Dr Nieba, who is currently the company’s Chief Technology Officer, replaces Eduardo Bravo who as of today has left Nordic Nanovector to pursue other career opportunities. “The Board is very pleased to appoint Lars Nieba as Nordic Nanovector’s […]
